The investment of around €7 million significantly enhances the site’s flexibility and capacity in synthesizing modern, complex and even corrosive molecules
The new reagents will bring the exceptional sensitivity of the company’s liquid format 1-step RT-qPCR reagents to a freeze-dryable format
The facility will produce 150 million vaccine doses per year
Since 1993, Beghou Consulting has helped life sciences companies - especially emerging pharmaceutical companies - establish and manage commercial operations to better market and sell therapies
Jointly fund and develop up to three antibody-drug conjugate programs for the treatment of cancer
Amit Jaju, Senior Managing Director, India in an interview with Thomas C Thottathil outlined the steps Indian pharma companies should follow to be compliant with global regulatory requirements
Despite advances over the past 20 years, ovarian cancer treatment requires better standard of care
Company to manufacture drug substance for clinical supply of HaemaLogiX’s lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facility in Guangzhou, China
The new centre will comprise a team of 50 highly experienced specialists
SOLOSEC is designed to be easy to take and one oral dose contains a complete course of treatment
Subscribe To Our Newsletter & Stay Updated
